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Abstract!
Testosterone production by Leydig cells declines during aging in both men and rodent
models. Previous results from our lab demonstrated that daily sperm production also
declines in aging rats and alterations in the estrogen environment of the testis contribute
to this decline. Importantly, estrogen treatment during aging was able to attenuate the
age-associated decline in sperm production. However, the cellular and molecular
mechanisms by which estrogen maintains sperm production remain unclear. These
experiments were designed to further investigate the effects of estrogen on sperm
production in an attempt to further define the cellular mechanisms regulated by estrogen
within the testis. This study compared untreated rats at 15 months of age to 18 month
old rats that were treated with either vehicle or estradiol-valerate once every third day
from 15 to 18 months. The first question addressed was whether the effects of estradiolvalerate were direct or indirect via changes in gonadotropin production. Pituitary
concentrations of LH and FSH were quantified, and no significant difference was found
between any of the three groups. This suggests that estrogen acts directly at the testis
to regulate spermatogenesis. Some reports suggest that Sertoli cell numbers decline
with age which would lead to reduced sperm production. Therefore, we next asked if
age or treatment with estradiol-valerate affected the number of Sertoli cells. GATA-4
positive Sertoli cells were counted from parallel sections using the physical dissector
method to estimate total number of Sertoli cells per testis. While the number of Sertoli
cells trended lower in 18 month control animals compared to either 15 month control or
18 month treated animals, these differences were not statistically different. This
suggests that spermatogenic efficiency, and not the number of somatic cells to support

spermatogenesis, is responsible for differences in sperm production during aging. Our
final question asked if the amount of apoptosis within the testis varied by age or
treatment. The percentage of seminiferous tubules in which apoptotic cells were
observed was similar between all three groups. Collectively, these results suggest that
estrogen likely regulates sperm production by affecting germ cell proliferation rates and
not germ cell survival. !

!
!

Introduction!
!

The testes are a pair of organs that lie in the scrotum of the male, and are the

site of spermatogenesis. The testes are also the primary site for androgen production in
males. The core of each testis is filled with convoluted structures called seminiferous
tubules, which contain two different types of cells. The first type of cells are the germ
cells which become sperm through a delicate process of spermatogenesis, and the
second type of cells are the sustenacular (sertoli) cells which provide protection and
nourishment to the sperm-producing germ cells. These sertoli cells are also connected
by tight junctions to form the blood-testis barrier to protect developing sperm from
circulating materials in the blood stream [McKinley et al., 2015].!
!

Once fully developed, the mature sperm are then released from the sertoli cells

into the lumen of the seminiferous tubules, a process called spermiation. In total, it
takes about 64 days for a premature spermatogonium to progress from the basement
membrane of a seminiferous tubule and become a mature spermatozoan ready to be
released in the seminiferous tubule lumen. While traveling from the basement
membrane to the lumen, the spermatogonia progresses through various stages before
becoming a spermatogonia. This is a continuous process occurring in the tubule, and
different germ cells are observed to be at all different stages all throughout the tubule,
ensuring that mature spermatozoa are continuously being released into the lumen
[Goodman, 2009].!
!

Once the mature spermatozoans are released into the lumen, they are then

transported via the efferent ductules to the epididymis where they become motile and
are stored. Upon arousal of the male, the sperm are transported from the epididymis to

the vas deferens, and finally to the urethra for ejaculation [Goodman, 2009; McKinley et
al., 2015].!
!

Two of the main steroid hormones involved in sexual reproduction, testosterone

and estradiol, are also produced in the testis, however they are produced by interstitial
(Leydig) cells, which surround the seminiferous tubules. These hormones are pivotal in
spermatogenesis, and when the environment of either is altered, disruptions occur in
spermatogenesis [Celec and Ostatnikova, 2003; Hess, 2003; McKinley et al., 2015].!
!

The two main functions of the testes, spermatogenesis and androgen production,

are closely controlled by two pituitary gonadotropic hormones, luteinizing hormone (LH)
and follicle stimulating hormone (FSH). The release of these two hormones from the
anterior pituitary gland is driven by the release of gonadotropin-releasing hormone
(GnRH) from the hypothalamus when stimulated to do so [Goodman, 2009]. The
release of GnRH, along with the hormones LH and FSH, is regulated by a negative
feedback loop from the testes to the hypothalamus and pituitary gland, collectively
referred to as the Hypothalamaic-Pituitary-Gonadal (HPG) Axis [Manetti and Honig,
2010]. LH stimulates the Leydig cells to produce testosterone, whereas FSH stimulates
sertoli cells directly to promote spermatogenesis. Testosterone is also converted to
dihydroxytestosterone (DHT) and estradiol in the testis, and excess of all three of these
steroids negatively feedback directly to the pituitary to inhibit further LH release and to
the hypothalamus to inhibit GnRH release. Overall, this decreases the amount of
testosterone being produced. During FSH stimulation to the sertoli cells, a glycoprotein
byproduct, inhibin, is produced [Goodman, 2009]. Similar to testosterone, DHT, and
estradiol, inhibin incorporates a negative feedback mechanism to the pituitary to inhibit

further FSH release. However, unlike testosterone, DHT, and estradiol, inhibin does not
feedback to the hypothalamus [Manetti and Honig, 2010]. Thus, the HPG axis acts to
closely regulate the rate of spermatogenesis along with the amount of androgen
formation in order to meet the needs of the testis at a given time.!
!

Although testosterone is traditionally considered the primary steroid in males,

and estrogen is traditionally considered the primary steroid in females, recent studies
have demonstrated the importance of estrogen in males and male fertility. This is
observed by Robertson et al. [1999], who reported that aromatase knockout mice were
developmentally normal, however they were infertile due to disruption in
spermatogenesis. Also, estrogen receptor alpha (ESR1) and beta (ESR2) are
expressed in the testis and epididymis of various species including rats and humans
[Carreau et al., 2010], further suggesting a regulatory role played by estrogen in the
testes with fertility. Furthermore, estrogen receptors (ESR2) have been found directly on
spermatids, strongly suggesting that there could be a major regulatory role directly at
the sperm themselves [Carreau et al., 2011; Pentikainen et al., 200].!
!

As males age, testosterone production by leydig cells declines in both men and

rodent models, which is known to secondarily cause decreases in energy, muscle mass,
and sex drive. [Tenover, 2003; Zirkin and Tenover, 2012]. Decreased leydig cell function
also leads to a decrease in estrogen levels in the testes as well. !
!

Previous results from our lab further demonstrated the importance in the role of

estrogen in spermatogenesis. Daily sperm production (DSP) was measured in aging
rats, and was observed to be significantly declined in 18 month-old rat models (49.8 ±
2.6 x 106 sperm) compared to 15 month-old rat models (71.0 ± 2.6 x 106 sperm).

However, 18 month-old estradiol valerate (EV) treated rat models were significantly
higher (60.6 ± 2.6 x 106 sperm) than age-matched controls, indicating that estrogen
treatment during aging was able to attenuate the age-associated decline in sperm
production significantly. As already discussed, testosterone production is known to
decrease in human models after the age of 40, leading to a state of hypogonadism, or
low free testosterone levels [Tenover, 2003], and this same trend is observed in aging
male rats [Zirkin and Tenover, 2012]. To evaluate its possible effects on
spermatogenesis, our lab previously found that testosterone levels dropped from 1.13 ±
0.71 ng/mg protein in 15 month old rats to 0.58 ± 0.25 ng/mg protein in 18 month old
rats, and this value was not significantly increased in 18 month old rats with EV
treatment (0.71 ± .046 ng/mg protein). Because EV treatment in 18 month old rats was
unable to attenuate the testosterone concentration decline, it was suggested that
hypogonadism in aging male rats was not the mechanism by which spermatogenesis
and DSP are maintained in an aging rat [Clarke and Pearl, 2014]. However, estrogen
concentrations were observed to be maintained in aging male rats with EV treatment,
and estrogen concentrations were significantly higher in the EV treated 18 month old
rats (19.54 ± 1.16 pg/mg protein) compared to their aged matched controls (12.66 ±
0.98 pg/mg protein) [Clarke and Pearl, 2014]. This data further contributes to the
observed importance of estrogen in maintaining spermatogenesis.!
!

The current experiments were designed to further investigate the effects of

estrogen on sperm production in an attempt to identify the cellular mechanisms
regulated by estrogen within the testis. First, we aimed to assess whether the effects of
estrogen are direct or indirect via changes in gonadotropins, and evaluated this by

quantifying LH and FSH in the pituitary. If there were significant changes in
gonadotropin levels at the pituitary with aging then it would suggest that estradiol in the
testis was limited due to lower gonadotropin levels from the pituitary, however if these
values were maintained in aging it would suggest that the estrogen environment was
becoming altered directly at the testis. Estradiol has also been implicated in stimulation
of germ cell proliferation and prevention of apoptosis [Carreau et al., 2001; Pentikainen
et al., 2000]. To address this question, the overall rate of apoptosis within the testis was
investigated. Additionally, estradiol has been implicated in sertoli cell survival in
developmental studies [Pentikainen et al., 2000] so we quantified the number of sertoli
cells in aging and estrogen treated animals to observe any discrepancies in overall
sertoli cell number in the testis.!

!
!

Methods:!
Animals: !
!

Retired breeding Sprague Dawley rats were obtained from Charles River at 9

months of age and were individually housed in the WMU animal facility with ad libitum
access to food and water. At 15 months of age animals were divided into three groups
(n = 3 per group): 15 month control; 18 month vehicle control; 18 month estradiol
injected. Rats from these ages were chosen, because they correlated to human ages of
47 and 57 years of age, respectively. From 15-18 months of age animals were injected
subcutaneously with vehicle (isotonic saline/1% ethanol) or with 1 µg/kg estradiol
valerate in an isotonic saline with 1% ethanol vehicle once every third day. Animals in
each group were euthanized at the appropriate age. Testes were then collected and
fixed for immunohistochemistry, frozen for quantification of steroids and western
blotting, or processed for sperm counts.!

!
Steroid and Hormone Concentrations:!
!

Snap frozen tissue was homogenized in a buffer consisting of 50 mM Tris-Base,

10 mM EDTA, 150 mM NaCl, 0.1% Tween 20 and protease inhibitors (CompleteMini;
Roche, Indianapolis, Indiana) at pH 7.6 for about 2 minutes using an OmniTip tissue
homogenizer (Bioexpress, Kaysville, UT). It was then centrifuged twice to remove any
unsolubilized tissue. It was first centrifuged at 2271 x g, and that supernate was recentrifuged at 13,500 x g. The remaining supernate was then assayed for testosterone
and estradiol by competitive ELISAs (ENZO Life Sciences). Steroid concentrations were
normalized to amount of protein present in the homogenate as determined by a BCA

protein assay (EMD Millipore; Billerica, MA). The range of the estradiol standard curve
was 15.6 to 1,000 pg/mL and assay sensitivity was 13.9 pg/mL. The range of the
standard curve for testosterone was 7.81 to 2,000 pg/mL and assay sensitivity was 5.7
pg/mL. Values reported are mean ng/mg of protein for testosterone and pg/mg protein
for estradiol. Sprague Dawley pituitary gland homogenates were sent to the University
of Virginia Center for Research in Reproduction, where the pituitary hormone
concentrations for luteinizing hormone (LH) and follicle stimulating hormone (FSH) were
measured.!

!
Immunohistochemistry (IHC): !
!

In order to quantify sertoli cells, IHC was performed using the avidin-biotin

complex method. Tissue was incubated overnight at 4ºC with GATA-4. After primary
antibody incubation sections were incubated with biotinylated secondary antibody
followed by an avidin biotin horseradish peroxidase complex (Vector Laboratories).
Staining was visualized using NovaRED (Vector Laboratories) and counterstained with
ImmunoMaster Hematoxylin. Slides were visualized by light microscopy. !

!
Sertoli Cell Number:!
!

GATA-4 positive Sertoli cells were counted in parallel sections using the physical

dissector counting method [Sterio, 1984] to estimate total number of Sertoli cells per
testis. Two parallel sections of 5 µm in thickness were cut from one testis on each rat,
and were placed on the same slide for counting. Pictures were then taken from 9
separate quadrants of these sections, and were taken in the exact location on each

section. In order to ensure consistency, the area of each quadrant evaluated was 96.8
mm, for a total of 871.22 mm of area evaluated per testis section. The identical pictures
from each section were then observed and compared under the light microscope with a
40X objective lens for stained Sertoli cells. As described by Sterio [1984], a cell was
considered “positive” if it was seen in one of the pictures and was unseen in the exact
location from the opposite section. The sertoli cell per testis value for each rat was
calculated by multiplying the total testis volume (µm3) by the sertoli cells per volume
(µm-3). The total testis volume was calculated my multiplying the testis weight (in grams)
by a conversion factor (1012) in order to get a testis volume reported in µ3. Sertoli cells
per volume (Nv) was calculated by multiplying the total area evaluated per testis section
(871.22 mm for each section) by the thickness of the two parallel sections (2 x 5 µm =
10 µm), and dividing the total number of sertoli cells counted per testis by that value.
The mean sertoli cell value per testis for each group was then calculated by adding the
sertoli cell per testis values for each of the three individual mice belonging to each
group, and dividing that value by three. Mean sertoli cell values from each group were
then reported.!
!
Apoptosis: !
!

Apoptotic germ cells were detected using the TUNEL staining kit. If the germ cell

retained the brown colored stain, it was considered positive. Testes were observed
under the light microscope using a 40X objective lens. Four random sections of testes
were observed with no overlapping of other sections. The number of seminiferous
tubules displaying apoptotic cells per section were counted along with the total number

of seminiferous tubules per section. Percentage of seminiferous tubules per testis
displaying apoptosis was then calculated for each animal by adding up the total positive
tubules from all 4 sections and dividing that number by the total number of tubules
counted from all 4 sections. A tubule was positive if there was at least one apoptotic cell
in the tubule.!
!
Data Analysis: !
!

Data were analyzed by ANOVA using SAS. If the overall ANOVA was significant,

differences between groups were compared by single degree of freedom contrasts. All
values reported are mean ± SEM.!

!
!

Results:!
Sperm Production!
!

Detergent resistant spermatids were counted in order to calculate sperm per

gram of testis and daily sperm production (DSP) in 15 month untreated, 18 month
vehicle treated, and 18 month estradiol valerate treated rats (Figure 1). Sperm per gram
was significantly decreased at 18 months (49.82 ± 4.88 million) compared to 15 months
(70.98 ± 4.88 million). Testis weight was not significantly different at any of the ages. A
small, but not significant increase was observed in sperm per gram of testis and testis
weight in 18 month old treated animals compared to 18 month vehicle controls. Daily
sperm production (x106) was significantly reduced at 18 months (49.8 ± 2.6) compared
to 15 months (71.0 ± 2.6). However, daily sperm production in 18 month estradiol
treated animals was significantly higher than age matched controls (60.6 ± 2.6) [Clarke
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Figure 1. Sperm production and testis weight of aging rats and rats treated with
estradiol. a vs b vs c; p < 0.05.!

!
!
!

Steroid Concentrations!
!

In order to determine the effect of aging on steroid hormone concentrations,

intratesticular testosterone and estradiol amounts were quantified from 15 month
untreated, 18 month vehicle treated, and 18 month estradiol valerate (EV) treated rats
using competitive ELIZAs (Table 1). Testosterone concentrations were observed to be
1.13 ± 0.71, 0.58 ± 0.25, and 0.71 ± 0.46 ng/mg protein at 15 months, 18 months, and
18 month plus EV, respectively. Although testosterone concentration was highest at 15
months, there were no statistical significances between the values. Estradiol
concentrations were observed to be 19.14 ± 2.64, 12.55 ± 0.98, and 19.54 ± 1.16 pg/mg
protein at 15 months, 18 months, and 18 month EV, respectively (Table 1). There was a
statistically significant decrease between 15 month and 18 month vehicle treated rats,
however this decreased was attenuated in 18 month EV treated rats. Thus, there was
not a statistically significant difference in the estradiol concentrations between 15 month
untreated rats compared to the 18 month EV treated rats.!

Steroid

15 month

18 month

18 month + E

Testosterone!
(ng/mg protein)

1.13 ± 0.71

0.58 ± 0.25

0.71 ± 0.46

Estradiol!
(pg/mg protein)

19.14 ± 3.64

12.66 ± 0.98

19.54 ± 1.16

Table 1. Intratesticular steroid concentrations. a vs b indicates p < 0.05.!

!
!
!

Pituitary Gonadotropin Concentrations!
!

To assess whether the effects of estrogen are acting directly at the testis, or

whether they are indirectly effecting spermatogenesis via pituitary gonadotropin
secretion, we measured the concentrations of LH and FSH in 15 month, 18 month
vehicle treated, and 18 month EV treated rats (Table 2). LH concentrations were 2.22 ±
0.24, 2.75 ± 0.27, and 2.38 ± 0.13 µg/pituitary in 15 month, 18 month vehicle treated,
and 18 month EV treated animals, respectively. FSH concentrations were 3.68 ± 0.71,
3.32 ± 0.25, and 3.10 ± 0.20 µg/pituitary in 15 month, 18 month vehicle treated, and 18
month EV treated rats, respectively. There were no significant differences between any
of the values for LH and FSH. Specifically, LH and FSH concentrations were similar
between estrogen treated animals and age-matched control animals. Thus, any effects
on sperm production are likely mediated by estradiol acting at the testis.!

Gonadotropin

15 month

18 month

18 month + E

LH !
(µg/pituitary)

2.22 ± 0.24

2.75 ± 0.27

2.38 ± 0.13

FSH !
(µg/pituitary)

3.67 ± 0.71

3.32 ± 0.25

3.10 ± 0.20

Table 2. Pituitary gonadotropin concentration. LH and FSH within the pituitary of each
age/treatment group was determined by RIA.!

!
Sertoli Cell Number!
!

Sertoli cells are critical for sperm production, and have been suggested to

decrease with age. To survey whether estradiol concentration changes correlate to a

change in sertoli cell number, we quantified mean sertoli cells per testis. Cells were
considered to be “positive” if they retained the dark red GATA-4 stain (Figure 2). Sertoli
cell concentrations (x106) trended lower in 18 month vehicle treated rats (59.56 ± 2.03)
compared to 15 month old untreated rats (69.18 ± 5.98). There appeared to be an
increase in mean sertoli cells per testis in 18 month EV treated mice (66.95 ± 2.44)
compared to aged match controls by around 7 x 106 sertoli cells (Table 3). While not
significantly different, it is possible that this is biologically relevant, and with a greater n,
this may prove to be significant and is worth further analysis in more animals. Unrelated
to the sertoli cells that we were looking for, we also noticed that the acrosomes retained
the stain, which is found to be a common trend in staining sertoli cells with GATA-4. This
observed trend could be used for future analyses requiring testes staging [McCulsky et
al., 2009].!
!
Figure 2. Representative section of a Sprague
Dawley rat testis stained for GATA-4. Positive
sertoli cell nuclei for GATA-4 are stained red.
The sperm acrosome is also positive for GATA-4.!

!
!
!

15 month

18 month

18 month + E

Sertoli cells!
(x10^6)

69.18 ± 5.98

59.56 ± 2.03

66.95 ± 2.44

Apoptosis !
(% tubules)

15.37 ± 0.64

17.84 ± 1.73

15.48 ± 2.27

Table 3. Number of Sertoli cells per testis and percentage of apoptotic tubules within a
testis. !

!
Apoptosis!
!

The decrease in sperm production may be related to increased cell death with

age, and normal estradiol concentration has previously been suggested to prevent
apoptosis in a number of tissues. To evaluate whether decreased estradiol levels led to
increased germ cell apoptosis in the testis, TUNEL staining was performed. Tubules
were then observed under a light microscope and were determined to be positive if they
retained the TUNEL stain (Figure 3). Percentage of seminiferous tubules with at least
one apoptotic germ cell was then calculated for 15 month untreated rats, 18 month
vehicle treated rats, and 18 month EV treated rats (Table 3). There was about a 2.5%
increase in apoptosis in the 18 month vehicle treated group (17.84 ± 1.73%) compared
to the 15 month untreated group (15.37 ± 0.64%). This increase in apoptosis was not
observed in the 18 month plus EV group (15.48 ± 2.27%), as it was essentially the
same percentage as 15 month untreated group. However, there were no statistically
significant changes in apoptosis between the 15 month untreated, 18 month vehicle
treated, and 18 month EV treated animals.!

!

!
!
!
!
!
Figure 3. Representative section of a Sprague Dawley rat testis with TUNEL staining.
Positive germ cells are are stained brown. In this section two tubules are positive for
apoptotic cells. !

!
!
!

Discussion:!
!

Overall, these results suggest that the estrogen environment in the testis is

altered in aging male rats, and may play a very important role in daily sperm production.
DSP is significantly reduced in aging male rats, and estrogen treatment attenuates this
decline by approximately 50%. Pituitary gonadotropin concentrations were measured to
determine whether the effects of estrogen acted in an indirect manner by influencing
gonadotropin concentrations. LH acts on the leydig cells to stimulate testosterone
production, and testosterone may be then converted to estradiol via the aromatase
enzyme in the testis [Goodman, 2009; Hess, 2003]. Testosterone and estradiol may
then act to properly regulate spermatogenesis. However, FSH acts directly on the sertoli
cells to directly promote spermatogenesis [Goodman, 2009]. With any abnormal
variation in either of these important gonadotropins, rate of spermatogenesis could be
significantly decreased. As seen by the results of this experiment, LH and FSH
concentrations in the pituitary are relatively unchanged between all three experimental
groups. Although it is possible that serum FSH levels were elevated in our animals, we
do not believe that this is likely. The rats in our study were presumed to have normal
GnRH signaling pathways and a normal HPG axis, and the mechanism of FSH
synthesis and secretion argues against this theory. The FSHβ subunit assembles very
efficiently with the FSHα subunit in the pituitary, and upon forming this heterodimer FSH
in secreted via the constitutive pathway. Due to secretion via this type of pathway, very
little amounts of FSH are stored in the pituitary gland [Muyan et al., 1994; JablonkaShariff et al., 2008; Pearl et al., 2010]. In order for serum FSH levels to increase, it
would necessitate the increase of FSHβ concentration in the pituitary [Pearl et al.,

2010], however as already noted, pituitary FSH concentrations were relatively
unchanged between 15 month, 18 month, and 18 month + EV treated animals.
Collectively, this data suggests that the effects of estrogen on DSP are not indirect at
the pituitary through changes in gonadotropin concentrations. Instead, this data further
supports the hypothesis that estradiol acts directly at the testis in spermatogenesis
regulation.!
!

Sertoli cells play a pivotal role in maintaining spermatogenesis, and supporting

germ cells as they mature [McKinley et al., 2015; Thais et al., 2011]. As described by
Thais et al. [2011], sertoli cells are continuously dividing in the rat testis, and divide at a
maximum rate 20 days post-conception. After day 20 post-conception, sertoli cell
proliferation rate steadily declines. During adolescence, the sertoli cells are the primary
site for estrogen production, before having this role taken over by the conversion of
testosterone to estrogen via aromatase in the leydig cells as the rat becomes an adult
[Hess, 2003]. The sertoli cell environment remains relatively stable and quiescent during
adulthood, with each cell supporting 30-50 developing germ cells, all at different stages,
and through this support, they maintain spermatogenesis [Thais et al., 2011]. If
alterations in the sertoli cell environment were to occur in the testis with aging, thereby
lowering sertoli cell numbers, we would expect to see a change in spermatogenesis
efficiency as well. Therefore, sertoli cells per testis were counted in all three
experimental groups (15 month, 18 month, and 18 month + EV treated). If the
mechanism causing a decreased rate of spermatogenesis were to be due to decreasing
sertoli cells with age, we would expect to see a significantly lower number in 18 month
old rats compared to 15 month old rats. Estradiol has been implicated to assist in sertoli

cell survival [Pentikainen et al., 2000], so it would be expected that 18 month old + EV
treated mice would have higher sertoli cell concentrations than their aged match
controls. Although we observed a decrease in sertoli cell number between 15 month
and 18 month old rats, and a value in 18 month old + EV treated rats that was higher
than aged match controls and similar to the values observed in 15 month old rats, these
differences were not statistically significant. However, the difference in sertoli cell
number may still be biologically significant, and further analysis is necessary with a
larger n per group in order to make a definitive conclusion about the contribution of
sertoli cell number. Due to the large number of germ cells nurtured by one sertoli cell at
a given time, it may be that statistical significance is not an appropriate indicator as to
the impact a change in sertoli cell concentration has on maintaing spermatogenesis.!
!

Apoptosis is a naturally occurring mechanism used as a means of defense to

protect the testis from defective aging gametes [Johnson, 1995]. Although a normal
process, inordinate use of this mechanism can cause a reduced amount of developing
germ cells in the testis, thereby leading to a decreased rate of spermatogenesis and
overall amount of sperm. Estradiol has been known to prevent apoptosis from occurring
in non-reproductive tissues [Simpkins and Dykens, 2008; Vasconsuelo et al., 2011],
however its effects on germ cells in the testis are unknown. If there was an observed
increase in percentage of apoptosis between 15 month and 18 month old rats, we would
suspect to see a decreased percentage of apoptosis in 18 month + EV rats compared to
their age matched controls if the effects of estrogen on preventing apoptosis were
similar in germ cells and cells in non-reproductive tissues. A similar phenomenon was
observed with apoptosis that we observed with sertoli cell amounts. Percentage of

apoptosis was slightly higher in 18 month old rats compared to 15 month old rats, and
18 month + EV rats had a slightly lower apoptosis rate than their age matched controls,
however these differences are not significant. Due to the relatively close percentages in
apoptosis across all three experimental groups, we suggest that apoptosis is not the
cause for decreasing rates of spermatogenesis in aging males. Therefore, estrogen’s
effects on daily sperm production are most likely related to changes in germ cell
proliferation rates through the stages of spermatogenesis, and not changes in germ cell
survival with decreased apoptosis rates. !

!
!
!

Future Studies/Conclusion:!
!

For further confirmation of our findings, it would be beneficial to repeat this

experiment with a larger experimental group (n), as a larger group would provide
stronger evidence of the observed results. Also, further investigation regarding which
stage of spermatogenesis proliferation changes occur at would provide further
understanding of the exact location and time of sperm proliferation change. This would
allow for more specific treatment in aging males, and could provide insight as to where
to look for proliferation changes in aging male men as well. The findings from the study
contribute to the overall knowledge of male fertility, and may be used to further
understand the cause and location spermatogenesis changes.!

!
!
!
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